Capsadyn Use for the Treatment of Cannabinoid-Induced Hyperemesis Syndrome (CIHS)
About
The goal of this study is to quantify the utility of a non-noxious capsaicin-containing ointment in the emergency department care of patients suffering from CIHS. Patients using the ointment may require fewer pharmacologic interventions and have decreased lengths of stay.
Eligibility Criteria
Inclusion Criteria
- Age 18 and above
- Ability to provide informed consent
- Presented to ED with established diagnosis of CIHS, or strong clinical suspicion exists for CIHS
Exclusion Criteria
- Patient is pregnant
- Patient is non-English speaking
- Patient is in custody under police/Department of Corrections
Primary Investigator
Damon Kuehl, MD, is an emergency medicine physician with over 20 years of clinical and research experience. He is an associate professor of emergency medicine at the Virginia Tech Carilion School of Medicine and vice chair of research and academic affairs at Carilion Clinic. He is board-certified by the American Board of Emergency Medicine in emergency medicine. He attended the University of Minnesota for medical school and completed his emergency training at Stanford University. He completed a health research fellowship in health policy and economics at OHSU.
Contact Information
Bridget Switzer, MPH
Clinical Research Coordinator
Cameron Hooten, BS
Clinical Research Coordinator
